Analysed CARIS LIFE SCIENCES INC (CAI:NASDAQ) News Sources
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
02-09-2026
yahoo.com
Caris Life Sciences (CAI) Will Present Seven Studies At A Global Lung Conference
05-09-2026
yahoo.com
Could Caris Life Sciences (CAI) Be 7% Undervalued After Its Lung Cancer Research Update?
06-09-2026
yahoo.com
Caris Life Sciences Stock Jumped 10% Yesterday. Here’s Where Shares Could Go Further in 2026.
18-09-2026
tikr.com
Caris Life Sciences Coasts Past A Buy Point; Why This Texas Biotech Researcher Deserves A Look
22-09-2026
yahoo.com
Caris Life Sciences Unveils the Next Evolution of Liquid Biopsy with Enhanced Caris Assure
29-09-2026
yahoo.com
IPO Stock Of The Week: Caris Pulls Back After More Than Doubling In Just Two Months
02-10-2026
yahoo.com
Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026
14-10-2026
yahoo.com
Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
15-10-2026
yahoo.com
What is the current price of CARIS LIFE SCIENCES INC (CAI:NASDAQ)?
The current price of CARIS LIFE SCIENCES INC (CAI:NASDAQ) is $32.455.
CARIS LIFE SCIENCES INC (CAI:NASDAQ) absolute price change since previous trading day?
The absolute price change of CARIS LIFE SCIENCES INC (CAI:NASDAQ) since the previous trading day is $0.455.
CARIS LIFE SCIENCES INC (CAI:NASDAQ) percentage price change since previous trading day?
The percentage price change of CARIS LIFE SCIENCES INC (CAI:NASDAQ) since the previous trading day is 1.4219%.
What is the most recent average sentiment score for CARIS LIFE SCIENCES INC (CAI:NASDAQ)?
The most recent average sentiment score for CARIS LIFE SCIENCES INC (CAI:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for CARIS LIFE SCIENCES INC (CAI:NASDAQ)?
The most recent sentiment for CARIS LIFE SCIENCES INC (CAI:NASDAQ) is .
SEC-8K** Filing Available For CARIS LIFE SCIENCES INC (CAI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.